blood sampling [Study Per­for­mance]

posted by Ohlbe – France, 2007-11-04 01:29 (6796 d 14:58 ago) – Posting: # 1275
Views: 26,939

Dear drdds,

No guideline that I know of.

❝ if yes, what precausions to be taken in analysis?


I would suggest to specify in your protocol when you will be using real sampling times and when you will use nominal sampling times (e.g. deviation of more than x minutes, or x minutes before a specific time point and y minutes after, or x % deviation from nominal...).

❝ and what should be collection time points in crossover period??


Stick to the nominal time point in the protocol. No adjustment based on the deviation in Period I.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
98 visitors (0 registered, 98 guests [including 27 identified bots]).
Forum time: 17:27 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5